Funding
Turn ideas into impact
Show Me
Due: September 7, 2026
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
US $350,000
Type
Grant
Source
Federal
Opp Number
PAR-25-095
Due: September 7, 2026
Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-040
Due: September 7, 2026
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
US $200,000
Type
Grant
Source
Federal
Opp Number
PAR-25-096
Due: September 7, 2026
National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)
Type
Grant
Source
Federal
Opp Number
PAR-23-235
Due: September 7, 2026
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer’s Dementia (R21 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-064
Due: September 8, 2026
National Centers for Biomedical Imaging and Bioengineering (NCBIB)
US $750,000
Type
Grant
Source
Federal
Due: September 25, 2026
NHLBI Program Project Applications (P01 Clinical Trials Optional)
Type
Grant
Source
Federal
Opp Number
PAR-24-065
Due: September 25, 2026
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2024, 2025, and 2026 (P50 Clinical Trial Required)
Type
Grant
Source
Federal
Opp Number
PAR-23-284
Due: September 25, 2026
Utilizing Equipment to Study Environmental Extrinsic Factors and Enhance Rigor and Reproducibility of Animal Research (R24, Clinical Trials Not-Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-24-167
Submit your funding opportunity.
Do you have a grant, incentive, funding competition, or other funding source to share?